NCT05848414

Brief Summary

This study will be conducted to assess the baseline characteristics and evaluate the 90-day mortality of patients admitted with liver cirrhosis. Also, the study will be done to identify the risk factors of 90-day mortality.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Feb 2024

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 28, 2023

Completed
1 month until next milestone

First Posted

Study publicly available on registry

May 8, 2023

Completed
9 months until next milestone

Study Start

First participant enrolled

February 7, 2024

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 7, 2025

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 7, 2025

Completed
Last Updated

October 2, 2025

Status Verified

July 1, 2024

Enrollment Period

1.2 years

First QC Date

March 28, 2023

Last Update Submit

September 29, 2025

Conditions

Liver Cirrhosis

Outcome Measures

Primary Outcomes (1)

  • evaluate the 90-day mortality of patients admitted with liver cirrhosis

    Mortality

    90 days

Secondary Outcomes (1)

  • identify the risk factors of 90-day mortalit

    90 days

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All liver cirrhosis patients admitted to hospital

You may qualify if:

  • \- diagnosis of liver cirrhosis, adult (age ≥ 18 years old) and patients willing to give consent during the selected period.

You may not qualify if:

  • \- Patients with ages \< 18 years or patients that will be lost on follow-up will be excluded from the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Esraa Hassan Mohamed Kotbey

Asyut, Egypt

Location

Related Publications (1)

  • Tsochatzis EA, Bosch J, Burroughs AK. Liver cirrhosis. Lancet. 2014 May 17;383(9930):1749-61. doi: 10.1016/S0140-6736(14)60121-5. Epub 2014 Jan 28.

    PMID: 24480518BACKGROUND

MeSH Terms

Conditions

Liver Cirrhosis

Condition Hierarchy (Ancestors)

Liver DiseasesDigestive System DiseasesFibrosisPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Ahlam M Farghaly

    AhlamGastro2000@yahoo.com

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
3 Months
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Doctor

Study Record Dates

First Submitted

March 28, 2023

First Posted

May 8, 2023

Study Start

February 7, 2024

Primary Completion

May 7, 2025

Study Completion

July 7, 2025

Last Updated

October 2, 2025

Record last verified: 2024-07

Locations

EG(1)